VPHIF (Valeo Pharma) Scaled Net Operating Assets: -0.00 (As of Jul. 2024)


VPHIF Valeo Pharma Inc VPHIF
12 GF Score
Price $0.00
View Full Analysis

What is Valeo Pharma Scaled Net Operating Assets?

Valeo Pharma VPHIF -99.00% 12 Scaled Net Operating Assets is -0.00 as of Jul. 2024. GuruFocus rates VPHIF with a GF Score™ of 12/100.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Valeo Pharma's operating assets for the quarter that ended in Jul. 2024 was $18.28 Mil. Valeo Pharma's operating liabilities for the quarter that ended in Jul. 2024 was $18.34 Mil. Valeo Pharma's Total Assets for the quarter that ended in Apr. 2024 was $25.28 Mil. Therefore, Valeo Pharma's scaled net operating assets (SNOA) for the quarter that ended in Jul. 2024 was -0.00.

Valeo Pharma Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Valeo Pharma's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valeo Pharma Scaled Net Operating Assets Chart

Valeo Pharma Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.19 0.60 0.75 0.91 0.30

Valeo Pharma Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.37 0.23 0.14 -0.00

VPHIF vs ZTS: Scaled Net Operating Assets Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Valeo Pharma's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Valeo Pharma Scaled Net Operating Assets vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Valeo Pharma's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Valeo Pharma's Scaled Net Operating Assets falls into.


VPHIF
12GF Score
Valeo Pharma Inc VPHIF
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Valeo Pharma Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Valeo Pharma's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Oct. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Oct. 2023 )
=(Operating Assets (A: Oct. 2023 )-Operating Liabilities (A: Oct. 2023 ))/Total Assets (A: Oct. 2022 )
=(24.581-11.942)/42.563
=0.30

where

Operating Assets(A: Oct. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=30.052 - 5.471
=24.581

Operating Liabilities(A: Oct. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=59.469 - 44.121 - 3.406
=11.942

Valeo Pharma's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jul. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jul. 2024 )
=(Operating Assets (Q: Jul. 2024 )-Operating Liabilities (Q: Jul. 2024 ))/Total Assets (Q: Apr. 2024 )
=(18.281-18.335)/25.284
=-0.00

where

Operating Assets(Q: Jul. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=23.476 - 5.195
=18.281

Operating Liabilities(Q: Jul. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=69.439 - 17.818 - 33.286
=18.335

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of -0.00 mean?
Valeo Pharma (VPHIF) has a Scaled Net Operating Assets of -0.00 as of Jul. 2024. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Valeo Pharma and its competitors.
Is Valeo Pharma's Scaled Net Operating Assets too high?
Valeo Pharma's current Scaled Net Operating Assets is -0.00. Overall, Valeo Pharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Valeo Pharma's Scaled Net Operating Assets compare to ZTS?
Valeo Pharma's Scaled Net Operating Assets of -0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Drug Manufacturers company?
A good Scaled Net Operating Assets depends on the Drug Manufacturers industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Valeo Pharma and its competitors. Valeo Pharma's current Scaled Net Operating Assets is -0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valeo Pharma stock overvalued right now?
Valeo Pharma (VPHIF) has a current Scaled Net Operating Assets of -0.00. The current Scaled Net Operating Assets is -0.00. Valeo Pharma's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Valeo Pharma (VPHIF), the current Scaled Net Operating Assets is -0.00 as of Jul. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Valeo Pharma Business Description

Address 16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.
12GF Score

Get the complete analysis for VPHIF

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price